Evaluation and Comparison of Three Types of Spray Dried Coprocessed Excipient Avicel® for Direct Compression

BioMed Research International
Pavlína VodáčkováTomaš Solný

Abstract

As coprocessed excipients (CPE) gain a lot of focus recently, this article compares three commercially available CPE of Avicel brand, namely, CE 15, DG, and HFE 102. Comparison is based on measured physical properties of coprocessed mixtures, respectively, flow properties, pycnometric density, mean particle size, specific surface area, moisture content, hygroscopicity, solubility, pH leaching, electrostatic charge, SEM images, and DSC. Tablets were made employing three pressure sets. Viscoelastic properties and ejection force were assessed during compression, as well as pycnometric density, mass uniformity, height, tensile strength, friability, disintegration, and wetting times. Avicel CE 15 is of mid-range flow properties, contains mid-size and nonspherical particles, and has high hygroscopicity, growing negative charge, best lubricity, lowest tensile strength, and mid-long disintegration times. Avicel DG possesses the worst flow properties, small asymmetrical particles, lowest hygroscopicity, stable charge, intermediate lubricity, and tensile strength and exhibits fast disintegration of tablets. Finally, Avicel HFE 102 has the best flow properties, large symmetrical particles, and middle hygroscopicity and its charge fluctuat...Continue Reading

References

May 1, 1970·Journal of Pharmaceutical Sciences·J T Fell, J M Newton
Apr 17, 1999·International Journal of Pharmaceutics·M G Vachon, D Chulia
Dec 28, 1999·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·S WestermarckJ Yliruusi
Feb 9, 2000·Pharmaceutical Science & Technology Today·I JivrajC M Thomson
Mar 8, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·M Kuentz, H Leuenberger
Mar 29, 2000·Journal of Pharmaceutical Sciences·A BurgerH Stöttner
Mar 7, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·J S WuM T Sheu
Sep 2, 2005·Journal of Pharmaceutical Sciences·Changquan Calvin Sun
Dec 7, 2006·International Journal of Pharmaceutics·M George, T E Abraham
Feb 24, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Y GonnissenC Vervaet
Feb 28, 2007·International Journal of Pharmaceutics·Michael G Herting, Peter Kleinebudde
May 1, 2008·AAPS PharmSciTech·Rakhi B ShahMansoor A Khan
Sep 10, 2008·International Journal of Pharmaceutics·Sameer G LateAjay K Banga
Oct 16, 2008·Journal of Pharmaceutical Sciences·Yu PuCharles Cooney
Feb 26, 2009·Expert Opinion on Drug Delivery·Sumit Saha, Aliasgar F Shahiwala
Jan 22, 2010·Pharmaceutical Development and Technology·Sherif I F BadawyMunir Hussain
Apr 22, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Ingvild KlevanGöran Alderborn
Nov 9, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Joachim BrouwersEvelijn Zeijdner
Mar 31, 2011·Drug Development and Industrial Pharmacy·Sameh Abdel-Hamid, Gabriele Betz
May 14, 2011·Pharmaceutical Development and Technology·Sameh Abdel-Hamid, Gabriele Betz
Sep 29, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Alvaro GoyanesRamón Martínez-Pacheco
Jun 19, 2012·Indian Journal of Pharmaceutical Sciences·Rajashree MasareddyV Shah
Feb 8, 2013·Expert Opinion on Drug Delivery·Ali Al-khattawi, Afzal R Mohammed
Aug 15, 2013·Pharmaceutical Development and Technology·Raman Mahadevan IyerWaseem Malick
Jan 24, 2014·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Barbora Vraníková, Jan Gajdziok
Mar 4, 2014·Journal of Food Science and Technology·Deepak MudgilBhupendar Singh Khatkar
Jun 20, 2012·Carbohydrate Polymers·María D TorresMaría J Vázquez
Jul 6, 2014·International Journal of Pharmaceutics·Gregory ThoorensBrigitte Evrard
Oct 10, 2014·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Jan MuselíkIvana Lukášová
Mar 18, 2015·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Jitka MužíkováVáclav Lochař
Apr 7, 2015·International Journal of Pharmaceutics·SongTao WangRiccardo Panicucci
Jun 16, 2015·BioMed Research International·Barbora VraníkováDavid Vetchý
Jun 6, 2017·Drug Development and Industrial Pharmacy·Ian SoulairolTahmer Sharkawi
Jun 8, 2017·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Aleš FrancJan Muselík

❮ Previous
Next ❯

Software Mentioned

SpD
Avicel

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.